Candela Medical

General Information

We are a leading provider of advanced medical device solutions for a broad range of aesthetic applications. Our brands and products have been recognized for their innovation and as leaders in the high growth medical aesthetics space for almost 40 years. We provide energy-based solutions for primarily elective, cash pay procedures that utilize our leading technologies in laser, pulsed light, RF and microneedling. Our brand promise of “Science. Results. Trust.” guides our commitment to patients who can expect efficacious and clinically proven results when receiving a procedure involving a Candela device.

We seek to be the partner of choice for aesthetic practitioners by bringing the best technology solutions to their practices. Through our category-leading products, innovative treatments, robust clinical evidence, extensive post-sale support, and other value drivers, we facilitate practice growth and a quick return on their investment.

(Candela postponed its IPO “due to market conditions” on Oct. 27, 2021, hours ahead of when the IPO was scheduled for pricing.) 

Employees: 860
Founded: 1970
Contact Information
Address 251 Locke Drive, Marlborough, Massachusetts 01752, U
Phone Number (508) 358-7400
Web Address
View Prospectus: Candela Medical
Financial Information
Market Cap $1660.8mil
Revenues $390.2 mil (last 12 months)
Net Income $6.7 mil (last 12 months)
IPO Profile
Symbol CDLA
Exchange NASDAQ
Shares (millions): 14.7
Price range $16.00 - $18.00
Est. $ Volume $250.1 mil
Manager / Joint Managers BofA Securities/ Goldman Sachs/ Barclays
CO-Managers Baird/ Canaccord Genuity/ Stifel/ Oppenheimer & Co./ Stephens, Inc./ ING/ R. Seelaus & Co.
Expected To Trade: 10/28/2021
Status: Postponed
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change